Study Design and Participants

TE Thomas P Eisele
AB Adam Bennett
KS Kafula Silumbe
TF Timothy P Finn
VC Victor Chalwe
MK Mulakwa Kamuliwo
BH Busiku Hamainza
HM Hawela Moonga
EK Emmanuel Kooma
EK Elizabeth Chizema Kawesha
JY Joshua Yukich
JK Joseph Keating
TP Travis Porter
RC Ruben O Conner
DE Duncan Earle
RS Richard W Steketee
JM John M Miller
ask Ask a question
Favorite

A cluster-randomized controlled trial (CRCT) was used to evaluate the impact of the mass treatment interventions on study end points. The trial area was stratified into higher- and lower-transmission strata above and below 10% parasite prevalence at randomization. The study was conducted in Southern Province, Zambia along Lake Kariba in 60 health facility catchment areas (HFCAs) in 10 districts (Figure (Figure1).1). The entire study area was enumerated by a geographic information system in 2013 and 2014 using personal digital assistants. Approximately 330 000 individuals in 56 000 households, primarily of the Tonga ethnic group, live in this area. Malaria parasite prevalence in children ranges from <1% in areas inland from the lake to >25% in areas closer to the lake. The season for high malaria transmission lasts from January to May, coinciding with seasonal rains.

Map of the study area, divided into 60 health facility catchment areas that served as the unit of randomization. Abbreviations: fMDA, focal mass drug administration; MDA, mass drug administration; N, north.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A